Chemomab Therapeutics (STU:2QV0) YoY EPS Growth : 24.26% (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Chemomab Therapeutics YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Chemomab Therapeutics's YoY EPS Growth for the quarter that ended in Dec. 2024 was 24.26%.

Chemomab Therapeutics's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was €-0.15.

Chemomab Therapeutics YoY EPS Growth Historical Data

The historical data trend for Chemomab Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemomab Therapeutics YoY EPS Growth Chart

Chemomab Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EPS Growth

-138.65

-115.07

17.29

60.56

Chemomab Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EPS Growth	Get a 7-Day Free Trial															70.29	65.46	63.61	43.57	24.26

Chemomab Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Chemomab Therapeutics's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (A: Dec. 2024 )
=	(Earnings per Share (Diluted) (A: Dec. 2024 )	-	Earnings per Share (Diluted) (A: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (A: Dec. 2023 ) \|
=	(-0.745	-	-1.889)	/	\| -1.889 \|
=	60.56 %

Chemomab Therapeutics's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (Q: Dec. 2024 )
=	(Earnings per Share (Diluted) (Q: Dec. 2024 )	-	Earnings per Share (Diluted) (Q: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2023 )) \|
=	(-0.153	-	-0.202)	/	\| -0.202 \|
=	24.26 %

Chemomab Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Chemomab Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemomab Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chemomab Therapeutics Ltd (STU:2QV0) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

CMMB:USA

Address

Kiryat Atidim, Building 7, Tel Aviv, ISR, 6158002

Website

https://www.chemomab.com

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Chemomab Therapeutics Headlines

No Headlines